Teva Pharmaceuticals USA
Generic and biosimilar manufacturer.
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 25 quarterly filings, Teva Pharmaceuticals USA is a significant lobbying presence.
$1.4M
Total Lobbying Spend
25
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2020 | $100K |
| 2021 | $220K |
| 2022 | $360K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $240K |
Lobbying Firms
CAPITOL HILL CONSULTING GROUP
What They Lobby For
- Medicare reimbursement for biosimilars. Improving supply chain for products manufactured in the United States
- Issues surrounding US Pharmaceutical supply chain
- Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
- Issues surrounding Medicare reimbursement of generic drugs and biosimilars.
- Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
- Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. HHS and National Security Council for agencies.
- Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs.
- Generic Drug User Fee Amendments(GDUFA).
- Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act.
- Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.